IV heparin study after finger or hand reattachment
Part of Blood & lymphatic, Injuries & trauma clinical trials.
This study looks at whether giving an IV blood thinner called unfractionated heparin after finger/hand reattachment and restoring blood flow improves healing and safety. If you were accepted into the CEVARMU replant/revascularization program, this trial may be testing a standard-after-surgery medicine approach.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be accepted into the CEVARMU program at CHUM for replantation/revascularization (re-attachment and blood-flow restoration).
- You are not taking blood thinners such as warfarin (Coumadin), apixaban (Eliquis), rivaroxaban (Xarelto/Pradaxa-like), or similar medicines before admission (except aspirin/ASA).
- You should not have a known reason you cannot take heparin, such as bleeding problems, very low platelet count, active dangerous ulcers, severe liver disease, or being in shock.
- Your injury should not involve an amputation at or above the carpal-tunnel area (meaning not farther toward the arm than that point).
- Your injury should not include a degloving injury (skin/soft tissue separation from the body).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving a blood-thinner called heparin to all patients during a procedure through the wrist (radial artery) is better than giving it only when needed. The goal is to see which approach reduces the risk of the artery getting blocked afterward.
This trial looks at how well the hand works after surgically reattaching multiple fingers that were completely cut off. It aims to help patients understand what recovery might be like.
This trial tests a new approach for rehabilitation after an upper-limb amputation to help improve your ability to intentionally control a prosthetic and regain a sense of position (“proprioception”). You may be considered if you are planning an elective upper-arm or below-elbow amputation and can safely have surgery and follow up closely.
This trial compares two blood-thinning strategies after leg artery surgery or angioplasty to prevent dangerous blood clots. Participants will receive either rivaroxaban plus aspirin or aspirin alone, and researchers will monitor for clots over 30 days.
This study tests a blood-derived medicine (antithrombin) to help people who do not respond well to the blood thinner heparin during heart surgery. It aims to make surgery safer by improving blood thinning.
This trial tests whether starting enoxaparin (a blood-thinner) within 24 hours after placing a specific type of central line can prevent dangerous clots. It may help reduce clot risk in people whose line is placed in the neck or thigh vein, while also tracking bleeding side effects.
Hear when a new Amputation; Traumatic, Hand trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.